List of Excipients in API lasmiditan
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing lasmiditan
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Eli Lilly and Company | REYVOW | lasmiditan | 0002-4312 | CELLULOSE, MICROCRYSTALLINE | 2037-12-05 |
| Eli Lilly and Company | REYVOW | lasmiditan | 0002-4312 | CROSCARMELLOSE SODIUM | 2037-12-05 |
| Eli Lilly and Company | REYVOW | lasmiditan | 0002-4312 | FERROSOFERRIC OXIDE | 2037-12-05 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for lasmiditan
Excipient focus: CELLULOSE, MICROCRYSTALLINE
lasmiditan drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | lasmiditan | 0002-4312 |
| >Company | >Ingredient | >NDC |
lasmiditan drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
lasmiditan drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | lasmiditan | 0002-4312 |
| >Company | >Ingredient | >NDC |
lasmiditan drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
lasmiditan drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | lasmiditan | 0002-4312 |
| >Company | >Ingredient | >NDC |
lasmiditan drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
lasmiditan drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | lasmiditan | 0002-4312 |
| >Company | >Ingredient | >NDC |
lasmiditan drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
lasmiditan drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | lasmiditan | 0002-4312 |
| >Company | >Ingredient | >NDC |
lasmiditan drug variants not containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
lasmiditan drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | lasmiditan | 0002-4312 |
| >Company | >Ingredient | >NDC |
lasmiditan drug variants not containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
lasmiditan drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | lasmiditan | 0002-4312 |
| >Company | >Ingredient | >NDC |
lasmiditan drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
lasmiditan drug variants containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | lasmiditan | 0002-4312 |
| >Company | >Ingredient | >NDC |
lasmiditan drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TALC
lasmiditan drug variants containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | lasmiditan | 0002-4312 |
| >Company | >Ingredient | >NDC |
lasmiditan drug variants not containing TALC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
lasmiditan drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Eli Lilly and Company | lasmiditan | 0002-4312 |
| >Company | >Ingredient | >NDC |
lasmiditan drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2026 - 2027
NCE-1 Patent Challenge Dates 2026 - 2027
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2026, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch